www.hivandhepatitis.com

HR17: Overamping Is a Common Problem Among People Who Use Stimulants

Details
Category: HR17
Published on Wednesday, 17 May 2017 00:00
Written by Liz Highleyman
  • Print

Overdosing on stimulants such as methamphetamine -- known as "overamping" -- is an under-recognized problem in a harm reduction community that more often focuses on opioid overdose, according to a presentation at the 25th Harm Reduction International Conference this week in Montreal.

alt

Read more:

14. HIV Researchers and Advocates Killed in Plane Crash En Route to AIDS Conference

Details
Category: AIDS 2014
Published on Monday, 12 January 2015 00:00
Written by HIVandHepatitis.com
  • Print

The 2014 International AIDS Conference in Melbourne got off to a somber start in July after several HIV researchers and advocates en route to the meeting were killed on Malaysian Airlines flight MH17 from Amsterdam to Kuala Lumpur, which crashed after being hit by a missile near the Russia-Ukraine border.alt

Read more:

AIDS 2012 Conference Program Now Online, Global Village Events Free

Details
Category: AIDS 2012
Published on Friday, 15 June 2012 00:00
Written by Liz Highleyman
  • Print

The full program for the XIX International AIDS Conference (AIDS 2012) was announced this week and is now available online at www.aids2012.org. Abstracts, slides, posters, and webcasts of selected presentations will also added to the website throughout the meeting.alt

Read more:

IAS 2013: Adolescents with HIV Face Challenges Transitioning to Adulthood [VIDEO]

Details
Category: IAS 2013
Published on Monday, 01 July 2013 00:00
Written by Gregory Fowler
  • Print

Worldwide, a growing number of people infected with HIV as infants or young children and treated with antiretroviral therapy for many years are now reaching adulthood and face a challenging transition, researchers reported at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) this week in Kuala Lumpur.

alt

Read more:

EASL 2012: Boceprevir Improves Cure Rates for HIV/HCV Coinfection but Beware of Drug Interactions

Details
Category: EASL 2012
Published on Tuesday, 24 April 2012 00:00
Written by Liz Highleyman
  • Print

Adding boceprevir (Victrelis) to pegylated interferon and ribavirin for treatment of chronic hepatitis C in people with HIV substantially increased the likelihood of end-of-treatment response and sustained response 12 weeks after completing therapy, researchers reported at the 47th International Liver Congress (EASL 2012) last week in Barcelona.

alt

Read more:

More Articles...

  1. Previous Conferences
  2. IAS 2011: Inflammation Markers Linked to Liver Disease, Death in HIV/HBV and HIV/HCV Coinfection
  3. 18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
  4. Coverage of the 46th Annual Meeting of the European Association for the Study of the Liver
  5. HBV Genotype Predicts HBeAg Seroconversion on Tenofovir
  6. International AIDS Society WiIll Host International AIDS Conference in U.S. after a 22-year Absence
  7. CROI 2007: Another Report of Drug-resistant HIV in a Patient Treated with Entecavir (Baraclude) for Hepatitis B
  8. AASLD 2006: Liver Transplantation in HIV Positive Patients

Subcategories

Copyright © 2023 www.hivandhepatitis.com. All Rights Reserved. Designed by JoomlArt.com. Joomla! is Free Software released under the GNU General Public License.

Bread and Roses Web DesignWeb Design and Development by Bread and Roses Web Design